Monoclonal Rat anti-Mouse CD90.2 (Mouse) Antibody (clone 30H12, AF647)
Catalog Number: LS-C810655
2 sizes / from $259.00
Antibody: Rat Monoclonal
Applications: Flow Cytometry
Reactivity: Mouse
Format: Liquid
Flow cytometry of CD19 antibody This image was taken for the unconjugated form of this product. Other forms have not been tested.
Monoclonal Mouse anti-Human CD19 Antibody (clone BU12, FITC)
Primary AntibodyLSBio Guarantee
| Antibody: | Mouse Monoclonal |
| Applications: | Flow Cytometry, Functional Assay |
| Reactivity: | Human |
| Format: | Liquid |
$455.00each
Catalog Number: LS-C134319-120
Catalog Number: LS-C134319
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- CD19 antibody LS-C134319 is an FITC-conjugated mouse monoclonal antibody to human CD19. Validated for Flow and Func. Cited in 1 publication.
- Application
- FC, Func
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Monoclonal Antibodies
- Alternative Names
- B-lymphocyte antigen CD19 | CD19 | CD19 molecule | Differentiation antigen CD19 | T-cell surface antigen Leu-12 | B4 | CD19 antigen | CVID3
- UniProt Number
- P15391
- NCBI GenBank
- NM_001770 | NP_001761.3
- SwissProt
- P15391
Target
- Target
- Human CD19
- Antigen Species
- Human
- Epitope
- CD19 molecule of about 95 kd.
- Gene Name
- CD19
Antibody
- Host Species
- Mouse
- Clonality
- Monoclonal
- Clone
- BU12
- Isotype
- IgG1
Immunogen
- Immunogen
- Human EB-4 Burkitt lymphoma cell line.
- Immunogen Type
- Cell-Based Immunization
Format
- Conjugate/Label
- Fluorescein Isothiocyanate
- Format
- Liquid
- Formulation
- 50 mM Sodium Phosphate, pH 7.5, 150 mM NaCl, 100 mM KCl, 0.04% Sodium Azide, 5% Glycerol, 0.2% BSA
- Preservative
- Yes
- Purification Method
- Protein A Affinity
Storage & Handling
- Storage Conditions
- Store at 4°C. Do not freeze. Protect from light.
- Recommended Storage Buffer
- 50 mM Sodium Phosphate|150 mM NaCl
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell. Marco Ruella, Jun Xu, David M Barrett, Joseph A Fraietta, Tyler J Reich, David E Ambrose, Michael Klichinsky, Olga Shestova, Prachi R Patel, Irina Kulikovskaya, Farzana Nazimuddin, Vijay G Bhoj, Elena J Orlando, Terry J Fry, Hans Bitter, Shannon L Maude, Bruce L Levine, Christopher L Nobles, Frederic D Bushman, Regina M Young, John Scholler, Saar I Gill, Carl H June, Stephan A Grupp, Simon F Lacey, J Joseph Melenhorst. Nature medicine. 2018 Oct;24:1499-1503. PubMed: 30275568 PMC: PMC6511988
